(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di

(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di Struktur
CAS-Nr.
Englisch Name:
(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di
Synonyma:
(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di
CBNumber:
CB41565278
Summenformel:
C51H101NO5SSi4
Molgewicht:
0
MOL-Datei:
Mol file

(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di Eigenschaften

Sicherheit

(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di Chemische Eigenschaften,Einsatz,Produktion Methoden

(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Medical Isotopes --
stohler@medicalisotopes.com United States 6185 68

  • (3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-di
  • C51H101NO5SSi4
  • Chiral Reagents
Copyright 2019 © ChemicalBook. All rights reserved